177 related articles for article (PubMed ID: 32990407)
21. Profile of exhaled-breath volatile organic compounds to diagnose pancreatic cancer.
Markar SR; Brodie B; Chin ST; Romano A; Spalding D; Hanna GB
Br J Surg; 2018 Oct; 105(11):1493-1500. PubMed ID: 30019405
[TBL] [Abstract][Full Text] [Related]
22. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting.
Mangler M; Freitag C; Lanowska M; Staeck O; Schneider A; Speiser D
Ginekol Pol; 2012 Oct; 83(10):730-6. PubMed ID: 23383557
[TBL] [Abstract][Full Text] [Related]
23. Advanced Diagnostic Technology of Volatile Organic Compounds Real Time analysis Analysis From Exhaled Breath of Gastric Cancer Patients Using Proton-Transfer-Reaction Time-of-Flight Mass Spectrometry.
Jung YJ; Seo HS; Kim JH; Song KY; Park CH; Lee HH
Front Oncol; 2021; 11():560591. PubMed ID: 33996531
[TBL] [Abstract][Full Text] [Related]
24. Preliminary method for profiling volatile organic compounds in breath that correlate with pulmonary function and other clinical traits of subjects diagnosed with cystic fibrosis: a pilot study.
Woollam M; Siegel AP; Grocki P; Saunders JL; Sanders DB; Agarwal M; Davis MD
J Breath Res; 2022 Feb; 16(2):. PubMed ID: 35120338
[TBL] [Abstract][Full Text] [Related]
25. Breath Analysis for Lung Cancer Early Detection-A Clinical Study.
Jia Z; Thavasi V; Venkatesan T; Lee P
Metabolites; 2023 Dec; 13(12):. PubMed ID: 38132879
[TBL] [Abstract][Full Text] [Related]
26. Breath testing as potential colorectal cancer screening tool.
Amal H; Leja M; Funka K; Lasina I; Skapars R; Sivins A; Ancans G; Kikuste I; Vanags A; Tolmanis I; Kirsners A; Kupcinskas L; Haick H
Int J Cancer; 2016 Jan; 138(1):229-36. PubMed ID: 26212114
[TBL] [Abstract][Full Text] [Related]
27. Exhaled Breath Metabolomics for the Diagnosis of Pneumonia in Intubated and Mechanically-Ventilated Intensive Care Unit (ICU)-Patients.
van Oort PM; de Bruin S; Weda H; Knobel HH; Schultz MJ; Bos LD; On Behalf Of The Mars Consortium
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218729
[TBL] [Abstract][Full Text] [Related]
28. The Use of Selected Ion Flow Tube-Mass Spectrometry Technology to Identify Breath Volatile Organic Compounds for the Detection of Head and Neck Squamous Cell Carcinoma: A Pilot Study.
Chandran D; Ooi EH; Watson DI; Kholmurodova F; Jaenisch S; Yazbeck R
Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31242578
[No Abstract] [Full Text] [Related]
29. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study.
Phillips M; Gleeson K; Hughes JM; Greenberg J; Cataneo RN; Baker L; McVay WP
Lancet; 1999 Jun; 353(9168):1930-3. PubMed ID: 10371572
[TBL] [Abstract][Full Text] [Related]
30. VOC biomarkers identification and predictive model construction for lung cancer based on exhaled breath analysis: research protocol for an exploratory study.
Li W; Dai W; Liu M; Long Y; Wang C; Xie S; Liu Y; Zhang Y; Shi Q; Peng X; Liu Y; Li Q; Duan Y
BMJ Open; 2019 Aug; 9(8):e028448. PubMed ID: 31399453
[TBL] [Abstract][Full Text] [Related]
31. Breath analysis by mass spectrometry: a new tool for breast cancer detection?
Patterson SG; Bayer CW; Hendry RJ; Sellers N; Lee KS; Vidakovic B; Mizaikoff B; Gabram-Mendola SG
Am Surg; 2011 Jun; 77(6):747-51. PubMed ID: 21679645
[TBL] [Abstract][Full Text] [Related]
32. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study.
Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I
J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569
[TBL] [Abstract][Full Text] [Related]
33. Non-invasive phenotyping using exhaled volatile organic compounds in asthma.
Ibrahim B; Basanta M; Cadden P; Singh D; Douce D; Woodcock A; Fowler SJ
Thorax; 2011 Sep; 66(9):804-9. PubMed ID: 21749985
[TBL] [Abstract][Full Text] [Related]
34. Breath Fingerprint of Colorectal Cancer Patients Based on the Gas Chromatography-Mass Spectrometry Analysis.
Kononova E; Mežmale L; Poļaka I; Veliks V; Anarkulova L; Vilkoite I; Tolmanis I; Ļeščinska AM; Stonāns I; Pčolkins A; Mochalski P; Leja M
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338911
[TBL] [Abstract][Full Text] [Related]
35. Assessment of breath volatile organic compounds in acute cardiorespiratory breathlessness: a protocol describing a prospective real-world observational study.
Ibrahim W; Wilde M; Cordell R; Salman D; Ruszkiewicz D; Bryant L; Richardson M; Free RC; Zhao B; Yousuf A; White C; Russell R; Jones S; Patel B; Awal A; Phillips R; Fowkes G; McNally T; Foxon C; Bhatt H; Peltrini R; Singapuri A; Hargadon B; Suzuki T; Ng LL; Gaillard E; Beardsmore C; Ryanna K; Pandya H; Coates T; Monks PS; Greening N; Brightling CE; Thomas P; Siddiqui S
BMJ Open; 2019 Mar; 9(3):e025486. PubMed ID: 30852546
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Bio-VOC Sampler for Analysis of Volatile Organic Compounds in Exhaled Breath.
Kwak J; Fan M; Harshman SW; Garrison CE; Dershem VL; Phillips JB; Grigsby CC; Ott DK
Metabolites; 2014 Sep; 4(4):879-88. PubMed ID: 25532709
[TBL] [Abstract][Full Text] [Related]
37. Calculated indices of volatile organic compounds (VOCs) in exhalation for lung cancer screening and early detection.
Chen X; Muhammad KG; Madeeha C; Fu W; Xu L; Hu Y; Liu J; Ying K; Chen L; Yurievna GO
Lung Cancer; 2021 Apr; 154():197-205. PubMed ID: 33653598
[TBL] [Abstract][Full Text] [Related]
38. Prediction of lung cancer using volatile biomarkers in breath.
Phillips M; Altorki N; Austin JH; Cameron RB; Cataneo RN; Greenberg J; Kloss R; Maxfield RA; Munawar MI; Pass HI; Rashid A; Rom WN; Schmitt P
Cancer Biomark; 2007; 3(2):95-109. PubMed ID: 17522431
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis by Volatile Organic Compounds in Exhaled Breath in Exhaled Breath from Patients with Gastric and Colorectal Cancers.
Chung J; Akter S; Han S; Shin Y; Choi TG; Kang I; Kim SS
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613569
[TBL] [Abstract][Full Text] [Related]
40. Volatile Organic Compounds in Exhaled Breath of Idiopathic Pulmonary Fibrosis for Discrimination from Healthy Subjects.
Yamada YI; Yamada G; Otsuka M; Nishikiori H; Ikeda K; Umeda Y; Ohnishi H; Kuronuma K; Chiba H; Baumbach JI; Takahashi H
Lung; 2017 Apr; 195(2):247-254. PubMed ID: 28247041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
